ESO–EANS Rewrites the Rulebook on Spontaneous ICH: First Update Since 2014
The European Stroke Organization (ESO) has recently shared an insightful post on X:
”The new ESO–EANS guideline on intracerebral haemorrhage outlines best practice for acute care, surgery, and blood pressure control.”
To access the guideline, read the full article here.
Thorsten Steiner et al. shade light on the management of intracerebral haemorrhage in a newly published ”European Stroke Organisation (ESO) and European Association of Neurosurgical Societies (EANS) guideline on stroke due to spontaneous intracerebral haemorrhage” in the SAGE Journals.
The European Stroke Organisation (ESO) and European Association of Neurosurgical Societies (EANS) have updated their guidelines on spontaneous ICH for the first time since 2014.
Despite reviewing over 115,000 articles and including 208 studies, only a handful of strong recommendations emerged.
These include treating ICH patients in organised stroke units and lowering blood pressure to prevent recurrence.
- Strong evidence supports stroke unit care and blood pressure control for secondary prevention, while weak evidence backs prediction scores for macrovascular causes of ICH.
- Strong evidence discourages anti-inflammatory use outside trials, while weak evidence cautions against routine use of rFVIIa, platelet transfusions, early treatment restrictions, and isolated temperature or glucose control.
These and more findings highlight the ongoing need for high-quality trials embedded in clinical care.
Read the latest updates on thrombosis and bleeding disorders in Hemostasis Today.
-
Jul 11, 2025, 19:14ISTH 2025 for Cardiac Surgery: LEX-211 (FARES-II) Trial Shows Promising Results
-
Jul 11, 2025, 16:48GPAS 2025: Shaping the Future of Bleeding Disorder Care
-
Jul 10, 2025, 11:23HTRS Thanks CSL Behring for Its Ongoing Commitment to Research Support
-
Jul 9, 2025, 14:11Join Dr. Bethany Samuelson Bannow for a Virtual Event on Hemostasis and Cancer
-
Jul 9, 2025, 13:59Late-Breaking Insights from ISTH 2025: Rurioctocog Alfa Pegol in PUPs with Hemophilia A
-
Jul 12, 2025, 16:21Richard Buka։ Evolution’s Imprint on Blood, Natural Selection Shaping Today’s Hematologic Disorders
-
Jul 12, 2025, 15:337 Tesla MRI Sheds Light on END Mechanisms in Symptomatic MCA Stenosis
-
Jul 12, 2025, 15:221 in 100: Subclavian Steal Syndrome Revealed by LVO Stroke in Case with Persistent Trigeminal Artery
-
Jul 11, 2025, 18:50ICAS Not a Factor: Post-EVT Intensive BP Control within 24 hrs Worsens Outcomes
-
Jul 11, 2025, 17:57Need for Recanalization Strategies Reinforced in P1 and P2: PCA Stroke Poor Outcomes
-
Jul 7, 2025, 17:08Detecting Anti-Drug Antibodies to Emicizumab: A French Center’s Remarkable Experience
-
Jul 6, 2025, 21:00From Untouchable to Editable: How 21st-Century Gene Editing Breakthroughs Clash with Systemic Barriers
-
Mar 6, 2025, 17:15Olympus Announces Launch of Single-Use Hemostasis Clip
-
Jul 10, 2025, 18:25Dr. Carol Kasper: Honoring the Legacy
-
Jul 8, 2025, 08:26ASH and HVO Collaborate to Expand Hematology Training in LMICs
-
Jul 6, 2025, 15:02Patients as Experts: EHC Calls for Early Involvement in HTA Systems
-
Jul 6, 2025, 14:56Missed ISTH 2025? Congress Daily Has You Covered
-
Jul 6, 2025, 11:48Japan's Youth Engagement in Hemophilia Care: Where Even the Doctors Get It – HABIT Summit 2025